One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood.v124.21.4742.4742
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 6, 2014 |
 Citations: 3 |
Affiliation: University of Navarra, Alexandria University, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Dana-Farber Cancer Institute, Asklepios Klinik Altona, National and Kapodistrian University of Athens, Tris Pharma (United States), Novartis (Switzerland), Centre Hospitalier Universitaire de Nantes, Siriraj Hospital, Mahidol University, Novartis (France), Shanghai Changzheng Hospital, Emory University, Harvard University, Medical University of Warsaw, Gachon University Gil Hospital, University Hospital Schleswig-Holstein, University of Lübeck, Ankara University, Irmandade da Santa Casa de Misericórdia de São Paulo, Hospital São Paulo, Seoul National University Hospital
Efficacy and Safety Based on Duration of Treatment of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma in the Phase 3 Panorama 1 Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
